Dr. Abhishek Yadav
MBBS, MD (Medicine), DNB Medical Oncology, ECMO
Career
Experience Summary
- Attending Consultant in Medical Oncology at Rajiv Gandhi Cancer Institute and Research Centre from March 2018 till July 2018.
- Associate Consultant in Medical Oncology at Fortis Hospital Shalimarbagh, New Delhi from July 2018 till April 2019.
- Consultant and Unit Head in Medical Oncology at Yashoda Hospital, Kaushambi, Ghaziabad since April 2019 till now.
Educational Background
- DNB Medical Oncology from Rajiv Gandhi Cancer Institute and Research Centre, New Delhi in 2017
- ECMO (European Certificate in Medical Oncology) in 2017
-M.D Medicine from Pt.B.D.Sharma P.G.I.M.S, Rohtak, Haryana in year 2010.
-M.B.B.S from Pt.B.D.Sharma P.G.I.M.S, Rohtak, Haryana in year 2004.
Areas Of Expertise
- Cancer Immunotherapy
- Cancer Targeted therapy
- Hormone Therapy
- Novel Tyrosine Kinase Inhibitors
- Experimental and Research treatment for cancer
- All kind of chemotherapies for solid tumors
- Management of Haematological malignancies
Publications
Yadav A, Goyal P, Agrawal CR, Bothra SJ, Jain P, Choudhury KD, Gupta SK, Sharma M, Bajaj R, Upadhyay A, Dash P, Doval DC. Efficacy and tolerability of nimotuzumab in combination with chemotherapy in recurrent and metastatic squamous cell carcinoma of head and neck at a cancer center in Northern India. Indian J Cancer. 2020 Jan-Mar;57(1):76-83. doi: 10.4103/ijc.IJC_469_18. PMID: 32129298.
Sharma M, Talwar V, Maheshwari U, Koyyala VPB, Goel V, Goyal S, Dash PK, Batra U, Bajaj R, Yadav A, Goyal P, Doval DC. Role of Maintenance Gemcitabine in Advanced Carcinoma Gallbladder. South Asian J Cancer. 2020 Oct;9(4):204-208. doi: 10.1055/s-0040-1721216. Epub 2021 Jun 12. PMID: 34131572; PMCID: PMC8197654.
Batra U, Aggarwal M, Jain P, Goyal P, Yadav A, Maheshwari U, Mehta A. Clinical outcome study of crizotinib in immunohistochemistry-proven echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene among Indian patients with adenocarcinoma lung. South Asian J Cancer. 2018 Jan-Mar;7(1):61-64. doi: 10.4103/sajc.sajc_215_17. PMID: 29600239; PMCID: PMC5865102